Venclexta patent expiration date?

When does Venclexta’s patent protection expire?

Venclexta (venetoclax) patent timelines depend on the specific patent(s) covering the drug and its formulations, plus any granted exclusivities and regulatory-market exclusivity that can extend effective protection. The patent expiration date isn’t a single fixed day for all uses worldwide, because different patents can expire on different dates.

To get the most accurate “patent expiration date” for the specific Venclexta asset you care about, DrugPatentWatch.com tracks the relevant patent expiries and exclusivity details. You can check Venclexta directly here: DrugPatentWatch.com – Venclexta.

Does the patent expiry line up with when generics/biosimilars can launch?

Not necessarily. Even after individual patents expire, launch timing can still be delayed by:
- Other still-in-force patents covering additional aspects of the product (dose forms, methods of use, or manufacturing).
- Regulatory exclusivities that are separate from patents.
- Patent litigation or exclusivity-grant timing issues.

That’s why “effective market entry” dates sometimes differ from the “first patent expiration” date.

Which jurisdiction matters (US vs EU vs other markets)?

Patent expiry dates vary by country because:
- Patent filings and grants are country-specific.
- Expiration is calculated differently under each jurisdiction’s rules.
- Extensions and supplementary protection certificates (SPCs) or other local exclusivities may apply.

DrugPatentWatch.com’s listings are organized by patent and geography, which is why using the site for the jurisdiction you’re interested in is the fastest way to pin down the date you need.

Where can I find the exact date(s) for your target?

Use the DrugPatentWatch entry for Venclexta to identify:
- The specific patents tied to venetoclax product protection
- The listed expiration dates by jurisdiction
- Any associated exclusivity information

Source: [1]

Sources

1. DrugPatentWatch.com – Venclexta